GDM Patients and Serum Amyloid A and Interleukin-1 (IL-1) Receptor Antagonist
Clinical trial NCT04238936 · COMPLETED
Trial details
- NCT number
- NCT04238936
- Sponsor
- Kanuni Sultan Suleyman Training and Research Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-01-20
- Primary completion
- 2020-05-20
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.